Trial
NCT01672736
A Trial of ASP7487 (OSI-906) in Combination With Bortezomib for the Treatment of Relapsed Multiple Myeloma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University Health Network, Toronto
Collaborators
Multiple Myeloma Research Consortium; Astellas Pharma Inc
Condition
Multiple Myeloma
Intervention
ASP7487, Velcade, Dexamethasone
Why stopped
The Sponsor decided to stop further manufacture the study drug 'Linsitinib' in Nov 2015.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-09-13